News With measles cases rising, UK launches vaccination drive With measles cases rising, the UK has launched a campaign urging around a million families to book the new four-in-one MMRV vaccine.
News FDA clears GSK's Priorix, first new MMR vaccine in 50 years With vaccine hesitancy leading to a rise in measles cases, the FDA's approval of GlaxoSmi
News J&J cuts $3.3bn deal to buy eye drug developer Ollin Johnson & Johnson has agreed to buy Texas biotech Ollin Biosciences for $2.2bn upfront, adding a keenly anticipated therapy for ophthalmic disorders.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.